Nitsan Halevy

Nitsan Halevy has a comprehensive work experience in the medical and pharmaceutical field. Nitsan is currently serving as the Chief Medical Officer at Pluri since March 2021. Prior to this, they were the Chief Clinical Development Officer at Quark Pharmaceuticals from January 2019 to March 2021. Before joining Quark Pharmaceuticals, Nitsan worked as the VP Medical Innovation at Quark Pharmaceuticals Inc from January 2018 to March 2021. Nitsan has also held positions at Teva Pharmaceuticals as the Director of Global Clinical Development from April 2016 to January 2018, and at Novartis as a Clinical Research Medical Advisor from September 2011 to April 2016. Nitsan began their career as a Medical Intern at Sapir Medical Center in October 2004. Nitsan has also worked as a Data Manager and IRB Specialist at Partners Healthcare, Brigham and Women's Hospital from February 2006 to June 2009. Nitsan has further experience as a Graduate Research Assistant in Public Health at the School of Health Sciences - Ben Gurion University from January 2001 to 2003 and as an Undergraduate Research Assistant in Gastroenterology from January 1999 to January 2000.

Nitsan Halevy earned an MD degree in Health Sciences from Joyce and Irving Goldman Medical School. In 2010, they also obtained a RAC (Regulatory Affairs Certificate) with a focus on Medical Device Regulatory Affairs from the Regulatory Affairs Professional Society (RAPS).